Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 27, 2020	Sep. 29, 2019	Sep. 27, 2020	Sep. 29, 2019
Sales by segment of business
Sales to customers	$ 21,082	$ 20,729	$ 60,109	$ 61,312
Percent Change (as a percent)	1.70%		(2.00%)
U.S.
Sales by segment of business
Sales to customers	$ 11,086	10,791	$ 31,324	31,323
Percent Change (as a percent)	2.70%		0.00%
International
Sales by segment of business
Sales to customers	$ 9,996	9,938	$ 28,785	29,989
Percent Change (as a percent)	0.60%		(4.00%)
Consumer Health*
Sales by segment of business
Sales to customers	$ 3,514	3,469	$ 10,435	10,331
Percent Change (as a percent)	1.30%		1.00%
Consumer Health* | U.S.
Sales by segment of business
Sales to customers	$ 1,556	1,394	$ 4,853	4,369
Percent Change (as a percent)	11.60%		11.10%
Consumer Health* | International
Sales by segment of business
Sales to customers	$ 1,958	2,075	$ 5,582	5,962
Percent Change (as a percent)	(5.60%)		(6.40%)
Consumer Health* | OTC
Sales by segment of business
Sales to customers	$ 1,142	1,098	$ 3,639	3,249
Percent Change (as a percent)	4.00%		12.00%
Consumer Health* | OTC | U.S.
Sales by segment of business
Sales to customers	$ 601	477	$ 1,917	1,468
Percent Change (as a percent)	26.00%		30.60%
Consumer Health* | OTC | International
Sales by segment of business
Sales to customers	$ 541	621	$ 1,722	1,781
Percent Change (as a percent)	(12.90%)		(3.30%)
Consumer Health* | Skin Health/Beauty
Sales by segment of business
Sales to customers	$ 1,149	1,151	$ 3,273	3,443
Percent Change (as a percent)	(0.20%)		(5.00%)
Consumer Health* | Skin Health/Beauty | U.S.
Sales by segment of business
Sales to customers	$ 572	559	$ 1,767	1,810
Percent Change (as a percent)	2.40%		(2.40%)
Consumer Health* | Skin Health/Beauty | International
Sales by segment of business
Sales to customers	$ 577	592	$ 1,506	1,633
Percent Change (as a percent)	(2.70%)		(7.80%)
Consumer Health* | Oral Care
Sales by segment of business
Sales to customers	$ 412	379	$ 1,204	1,135
Percent Change (as a percent)	8.50%		6.00%
Consumer Health* | Oral Care | U.S.
Sales by segment of business
Sales to customers	$ 164	156	$ 510	462
Percent Change (as a percent)	5.50%		10.40%
Consumer Health* | Oral Care | International
Sales by segment of business
Sales to customers	$ 248	223	$ 694	673
Percent Change (as a percent)	10.70%		3.00%
Consumer Health* | Baby Care
Sales by segment of business
Sales to customers	$ 393	417	$ 1,110	1,254
Percent Change (as a percent)	(5.90%)		(11.50%)
Consumer Health* | Baby Care | U.S.
Sales by segment of business
Sales to customers	$ 91	91	$ 279	277
Percent Change (as a percent)	(1.00%)		0.50%
Consumer Health* | Baby Care | International
Sales by segment of business
Sales to customers	$ 302	326	$ 831	977
Percent Change (as a percent)	(7.20%)		(14.90%)
Consumer Health* | Women's Health
Sales by segment of business
Sales to customers	$ 230	255	$ 664	733
Percent Change (as a percent)	(9.60%)		(9.40%)
Consumer Health* | Women's Health | U.S.
Sales by segment of business
Sales to customers	$ 3	3	$ 10	9
Percent Change (as a percent)	(6.90%)		7.30%
Consumer Health* | Women's Health | International
Sales by segment of business
Sales to customers	$ 227	252	$ 654	724
Percent Change (as a percent)	(9.60%)		(9.60%)
Consumer Health* | Wound Care/Other
Sales by segment of business
Sales to customers	$ 189	168	$ 545	516
Percent Change (as a percent)	12.50%		5.80%
Consumer Health* | Wound Care/Other | U.S.
Sales by segment of business
Sales to customers	$ 125	109	$ 370	343
Percent Change (as a percent)	15.20%		8.00%
Consumer Health* | Wound Care/Other | International
Sales by segment of business
Sales to customers	$ 64	59	$ 175	173
Percent Change (as a percent)	7.40%		1.30%
PHARMACEUTICAL
Sales by segment of business
Sales to customers	$ 11,418	10,877	$ 33,304	31,650
Percent Change (as a percent)	5.00%		5.20%
PHARMACEUTICAL | U.S.
Sales by segment of business
Sales to customers	$ 6,438	6,340	$ 18,619	17,705
Percent Change (as a percent)	1.50%		5.20%
PHARMACEUTICAL | International
Sales by segment of business
Sales to customers	$ 4,980	4,537	$ 14,685	13,945
Percent Change (as a percent)	9.70%		5.30%
PHARMACEUTICAL | Immunology
Sales by segment of business
Sales to customers	$ 3,789	3,711	$ 10,950	10,428
Percent Change (as a percent)	2.10%		5.00%
PHARMACEUTICAL | Immunology | U.S.
Sales by segment of business
Sales to customers	$ 2,558	2,582	$ 7,330	7,124
Percent Change (as a percent)	(0.90%)		2.90%
PHARMACEUTICAL | Immunology | International
Sales by segment of business
Sales to customers	$ 1,230	1,129	$ 3,619	3,304
Percent Change (as a percent)	9.00%		9.50%
PHARMACEUTICAL | Immunology | REMICADE®
Sales by segment of business
Sales to customers	$ 921	1,136	$ 2,846	3,345
Percent Change (as a percent)	(18.90%)		(14.90%)
PHARMACEUTICAL | Immunology | REMICADE® | U.S.
Sales by segment of business
Sales to customers	$ 634	749	$ 1,852	2,324
Percent Change (as a percent)	(15.40%)		(20.30%)
PHARMACEUTICAL | Immunology | REMICADE® | U.S. Exports
Sales by segment of business
Sales to customers	$ 78	88	$ 321	226
Percent Change (as a percent)	(11.30%)		42.10%
PHARMACEUTICAL | Immunology | REMICADE® | International
Sales by segment of business
Sales to customers	$ 209	299	$ 673	795
Percent Change (as a percent)	(30.10%)		(15.30%)
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA®
Sales by segment of business
Sales to customers	$ 592	586	$ 1,667	1,673
Percent Change (as a percent)	0.90%		(0.40%)
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | U.S.
Sales by segment of business
Sales to customers	$ 312	313	$ 840	857
Percent Change (as a percent)	(0.40%)		(2.00%)
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | International
Sales by segment of business
Sales to customers	$ 280	273	$ 827	816
Percent Change (as a percent)	2.40%		1.30%
PHARMACEUTICAL | Immunology | STELARA®
Sales by segment of business
Sales to customers	$ 1,947	1,698	$ 5,463	4,661
Percent Change (as a percent)	14.70%		17.20%
PHARMACEUTICAL | Immunology | STELARA® | U.S.
Sales by segment of business
Sales to customers	$ 1,313	1,212	$ 3,668	3,152
Percent Change (as a percent)	8.40%		16.40%
PHARMACEUTICAL | Immunology | STELARA® | International
Sales by segment of business
Sales to customers	$ 634	487	$ 1,795	1,509
Percent Change (as a percent)	30.30%		19.00%
PHARMACEUTICAL | Immunology | TREMFYA®
Sales by segment of business
Sales to customers	$ 327	290	$ 965	742
Percent Change (as a percent)	13.10%		30.20%
PHARMACEUTICAL | Immunology | TREMFYA® | U.S.
Sales by segment of business
Sales to customers	$ 222	221	$ 650	565
Percent Change (as a percent)	0.40%		15.00%
PHARMACEUTICAL | Immunology | TREMFYA® | International
Sales by segment of business
Sales to customers	$ 105	69	$ 316	177
Percent Change (as a percent)	54.40%		78.70%
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY
Sales by segment of business
Sales to customers	$ 3	2	$ 9	8
Percent Change (as a percent)	35.60%		12.40%
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International
Sales by segment of business
Sales to customers	$ 3	2	$ 9	8
Percent Change (as a percent)	35.60%		12.40%
PHARMACEUTICAL | Infectious Diseases
Sales by segment of business
Sales to customers	$ 864	839	$ 2,662	2,547
Percent Change (as a percent)	3.00%		4.50%
PHARMACEUTICAL | Infectious Diseases | U.S.
Sales by segment of business
Sales to customers	$ 413	418	$ 1,265	1,162
Percent Change (as a percent)	(1.10%)		8.90%
PHARMACEUTICAL | Infectious Diseases | International
Sales by segment of business
Sales to customers	$ 451	421	$ 1,397	1,385
Percent Change (as a percent)	7.00%		0.90%
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine
Sales by segment of business
Sales to customers	$ 236	218	$ 716	639
Percent Change (as a percent)	8.10%		12.10%
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | U.S.
Sales by segment of business
Sales to customers	$ 11	12	$ 33	36
Percent Change (as a percent)	(12.00%)		(8.60%)
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | International
Sales by segment of business
Sales to customers	$ 226	206	$ 684	603
Percent Change (as a percent)	9.30%		13.30%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA®
Sales by segment of business
Sales to customers	$ 526	508	$ 1,615	1,566
Percent Change (as a percent)	3.50%		3.10%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | U.S.
Sales by segment of business
Sales to customers	$ 379	373	$ 1,154	1,032
Percent Change (as a percent)	1.50%		11.80%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | International
Sales by segment of business
Sales to customers	$ 147	135	$ 461	534
Percent Change (as a percent)	9.10%		(13.70%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES
Sales by segment of business
Sales to customers	$ 102	113	$ 331	342
Percent Change (as a percent)	(9.40%)		(3.20%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.
Sales by segment of business
Sales to customers	$ 24	33	$ 79	94
Percent Change (as a percent)	(26.60%)		(16.60%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | International
Sales by segment of business
Sales to customers	$ 78	80	$ 252	248
Percent Change (as a percent)	(2.30%)		1.80%
PHARMACEUTICAL | Neuroscience
Sales by segment of business
Sales to customers	$ 1,605	1,595	$ 4,850	4,762
Percent Change (as a percent)	0.60%		1.80%
PHARMACEUTICAL | Neuroscience | U.S.
Sales by segment of business
Sales to customers	$ 759	785	$ 2,285	2,172
Percent Change (as a percent)	(3.50%)		5.20%
PHARMACEUTICAL | Neuroscience | International
Sales by segment of business
Sales to customers	$ 846	810	$ 2,565	2,590
Percent Change (as a percent)	4.50%		(1.00%)
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate
Sales by segment of business
Sales to customers	$ 149	193	$ 469	544
Percent Change (as a percent)	(22.60%)		(13.80%)
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | U.S.
Sales by segment of business
Sales to customers	$ 43	84	$ 150	196
Percent Change (as a percent)	(49.20%)		(23.60%)
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | International
Sales by segment of business
Sales to customers	$ 107	109	$ 319	348
Percent Change (as a percent)	(2.00%)		(8.20%)
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA®
Sales by segment of business
Sales to customers	$ 926	851	$ 2,688	2,459
Percent Change (as a percent)	8.80%		9.30%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | U.S.
Sales by segment of business
Sales to customers	$ 585	554	$ 1,704	1,543
Percent Change (as a percent)	5.60%		10.50%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | International
Sales by segment of business
Sales to customers	$ 341	297	$ 983	916
Percent Change (as a percent)	14.90%		7.30%
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA®
Sales by segment of business
Sales to customers	$ 152	167	$ 475	528
Percent Change (as a percent)	(9.30%)		(10.10%)
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | U.S.
Sales by segment of business
Sales to customers	$ 70	79	$ 220	237
Percent Change (as a percent)	(11.00%)		(6.90%)
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | International
Sales by segment of business
Sales to customers	$ 81	89	$ 254	292
Percent Change (as a percent)	(7.80%)		(12.70%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE
Sales by segment of business
Sales to customers	$ 377	384	$ 1,218	1,231
Percent Change (as a percent)	(1.80%)		(1.10%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.
Sales by segment of business
Sales to customers	$ 60	68	$ 210	196
Percent Change (as a percent)	(11.30%)		7.10%
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International
Sales by segment of business
Sales to customers	$ 317	316	$ 1,008	1,035
Percent Change (as a percent)	0.30%		(2.60%)
PHARMACEUTICAL | Oncology
Sales by segment of business
Sales to customers	$ 3,129	2,761	$ 8,933	7,976
Percent Change (as a percent)	13.30%		12.00%
PHARMACEUTICAL | Oncology | U.S.
Sales by segment of business
Sales to customers	$ 1,267	1,171	$ 3,623	3,146
Percent Change (as a percent)	8.20%		15.20%
PHARMACEUTICAL | Oncology | International
Sales by segment of business
Sales to customers	$ 1,862	1,590	$ 5,310	4,830
Percent Change (as a percent)	17.10%		9.90%
PHARMACEUTICAL | Oncology | DARZALEX®
Sales by segment of business
Sales to customers	$ 1,099	765	$ 2,937	2,168
Percent Change (as a percent)	43.80%		35.50%
PHARMACEUTICAL | Oncology | DARZALEX® | U.S.
Sales by segment of business
Sales to customers	$ 585	402	$ 1,540	1,123
Percent Change (as a percent)	46.00%		37.20%
PHARMACEUTICAL | Oncology | DARZALEX® | International
Sales by segment of business
Sales to customers	$ 514	363	$ 1,397	1,045
Percent Change (as a percent)	41.50%		33.70%
PHARMACEUTICAL | Oncology | ERLEADA
Sales by segment of business
Sales to customers	$ 206	86	$ 519	216
PHARMACEUTICAL | Oncology | ERLEADA | U.S.
Sales by segment of business
Sales to customers	152	74	407	194
PHARMACEUTICAL | Oncology | ERLEADA | International
Sales by segment of business
Sales to customers	55	12	112	22
PHARMACEUTICAL | Oncology | IMBRUVICA®
Sales by segment of business
Sales to customers	$ 1,031	921	$ 3,011	2,536
Percent Change (as a percent)	11.90%		18.70%
PHARMACEUTICAL | Oncology | IMBRUVICA® | U.S.
Sales by segment of business
Sales to customers	$ 450	447	$ 1,329	1,163
Percent Change (as a percent)	0.70%		14.20%
PHARMACEUTICAL | Oncology | IMBRUVICA® | International
Sales by segment of business
Sales to customers	$ 581	475	$ 1,682	1,373
Percent Change (as a percent)	22.50%		22.50%
PHARMACEUTICAL | Oncology | VELCADE®
Sales by segment of business
Sales to customers	$ 105	149	$ 311	636
Percent Change (as a percent)	(30.10%)		(51.20%)
PHARMACEUTICAL | Oncology | VELCADE® | U.S.
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
PHARMACEUTICAL | Oncology | VELCADE® | International
Sales by segment of business
Sales to customers	$ 105	149	$ 311	636
Percent Change (as a percent)	(30.10%)		(51.20%)
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate
Sales by segment of business
Sales to customers	$ 590	741	$ 1,848	2,118
Percent Change (as a percent)	(20.40%)		(12.70%)
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | U.S.
Sales by segment of business
Sales to customers	$ 58	233	$ 284	616
Percent Change (as a percent)	(75.20%)		(53.90%)
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | International
Sales by segment of business
Sales to customers	$ 532	508	$ 1,564	1,502
Percent Change (as a percent)	4.80%		4.10%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY
Sales by segment of business
Sales to customers	$ 98	100	$ 308	303
Percent Change (as a percent)	(1.70%)		1.70%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 21	17	$ 63	51
Percent Change (as a percent)	35.30%		25.80%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | International
Sales by segment of business
Sales to customers	$ 76	83	$ 244	252
Percent Change (as a percent)	(8.80%)		(3.10%)
PHARMACEUTICAL | Pulmonary Hypertension
Sales by segment of business
Sales to customers	$ 749	654	$ 2,283	2,000
Percent Change (as a percent)	14.50%		14.10%
PHARMACEUTICAL | Pulmonary Hypertension | U.S.
Sales by segment of business
Sales to customers	$ 510	427	$ 1,541	1,296
Percent Change (as a percent)	19.40%		18.90%
PHARMACEUTICAL | Pulmonary Hypertension | International
Sales by segment of business
Sales to customers	$ 239	227	$ 742	704
Percent Change (as a percent)	5.20%		5.30%
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT®
Sales by segment of business
Sales to customers	$ 392	347	$ 1,187	1,001
Percent Change (as a percent)	13.00%		18.60%
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | U.S.
Sales by segment of business
Sales to customers	$ 244	206	$ 729	581
Percent Change (as a percent)	18.10%		25.30%
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | International
Sales by segment of business
Sales to customers	$ 148	140	$ 458	419
Percent Change (as a percent)	5.50%		9.30%
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI®
Sales by segment of business
Sales to customers	$ 260	210	$ 792	611
Percent Change (as a percent)	23.60%		29.60%
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | U.S.
Sales by segment of business
Sales to customers	$ 226	185	$ 692	536
Percent Change (as a percent)	22.40%		29.10%
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | International
Sales by segment of business
Sales to customers	$ 34	25	$ 100	75
Percent Change (as a percent)	32.30%		33.10%
PHARMACEUTICAL | Pulmonary Hypertension | OTHER PULMONARY HYPERTENSION
Sales by segment of business
Sales to customers	$ 97	96	$ 304	388
Percent Change (as a percent)	0.10%		(21.70%)
PHARMACEUTICAL | Pulmonary Hypertension | OTHER PULMONARY HYPERTENSION | U.S.
Sales by segment of business
Sales to customers	$ 40	36	$ 121	179
Percent Change (as a percent)	11.50%		(32.30%)
PHARMACEUTICAL | Pulmonary Hypertension | OTHER PULMONARY HYPERTENSION | International
Sales by segment of business
Sales to customers	$ 57	61	$ 183	210
Percent Change (as a percent)	(6.70%)		(12.70%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other
Sales by segment of business
Sales to customers	$ 1,281	1,316	$ 3,625	3,936
Percent Change (as a percent)	(2.60%)		(7.90%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.
Sales by segment of business
Sales to customers	$ 931	955	$ 2,574	2,804
Percent Change (as a percent)	(2.60%)		(8.20%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International
Sales by segment of business
Sales to customers	$ 351	360	$ 1,052	1,131
Percent Change (as a percent)	(2.70%)		(7.10%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO®
Sales by segment of business
Sales to customers	$ 630	613	$ 1,716	1,704
Percent Change (as a percent)	2.90%		0.70%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | U.S.
Sales by segment of business
Sales to customers	$ 630	613	$ 1,716	1,704
Percent Change (as a percent)	2.90%		0.70%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | International
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET®
Sales by segment of business
Sales to customers	$ 224	179	$ 578	558
Percent Change (as a percent)	24.70%		3.60%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | U.S.
Sales by segment of business
Sales to customers	$ 156	125	$ 405	411
Percent Change (as a percent)	24.70%		(1.60%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | International
Sales by segment of business
Sales to customers	$ 68	55	$ 173	147
Percent Change (as a percent)	24.70%		18.00%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX®
Sales by segment of business
Sales to customers	$ 132	198	$ 423	607
Percent Change (as a percent)	(33.30%)		(30.40%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | U.S.
Sales by segment of business
Sales to customers	$ 69	126	$ 215	387
Percent Change (as a percent)	(45.40%)		(44.50%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | International
Sales by segment of business
Sales to customers	$ 63	72	$ 208	220
Percent Change (as a percent)	(12.20%)		(5.50%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER PULMONARY HYPERTENSION
Sales by segment of business
Sales to customers	$ 294	325	$ 908	$ 1,067
Percent Change (as a percent)	(9.50%)			(14.90%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER PULMONARY HYPERTENSION | U.S.
Sales by segment of business
Sales to customers	$ 75	91	$ 238	$ 302
Percent Change (as a percent)	(17.90%)		(21.40%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER PULMONARY HYPERTENSION | International
Sales by segment of business
Sales to customers	$ 219	234	$ 670	765
Percent Change (as a percent)	(6.20%)		(12.30%)
MEDICAL DEVICES
Sales by segment of business
Sales to customers	$ 6,150	6,383	$ 16,370	19,331
Percent Change (as a percent)	(3.60%)		(15.30%)
MEDICAL DEVICES | U.S.
Sales by segment of business
Sales to customers	$ 3,092	3,057	$ 7,852	9,249
Percent Change (as a percent)	1.20%		(15.10%)
MEDICAL DEVICES | International
Sales by segment of business
Sales to customers	$ 3,058	3,326	$ 8,518	10,082
Percent Change (as a percent)	(8.10%)		(15.50%)
MEDICAL DEVICES | Interventional Solutions
Sales by segment of business
Sales to customers	$ 836	741	$ 2,153	2,223
Percent Change (as a percent)	12.90%		(3.10%)
MEDICAL DEVICES | Interventional Solutions | U.S.
Sales by segment of business
Sales to customers	$ 399	357	$ 1,019	1,066
Percent Change (as a percent)	11.80%		(4.40%)
MEDICAL DEVICES | Interventional Solutions | International
Sales by segment of business
Sales to customers	$ 437	382	$ 1,134	1,156
Percent Change (as a percent)	14.00%		(2.00%)
MEDICAL DEVICES | Orthopaedics
Sales by segment of business
Sales to customers	$ 2,083	2,138	$ 5,572	6,566
Percent Change (as a percent)	(2.60%)		(15.10%)
MEDICAL DEVICES | Orthopaedics | U.S.
Sales by segment of business
Sales to customers	$ 1,308	1,301	$ 3,427	3,950
Percent Change (as a percent)	0.60%		(13.20%)
MEDICAL DEVICES | Orthopaedics | International
Sales by segment of business
Sales to customers	$ 774	837	$ 2,145	2,616
Percent Change (as a percent)	(7.50%)		(18.00%)
MEDICAL DEVICES | Orthopaedics | HIPS
Sales by segment of business
Sales to customers	$ 345	336	$ 908	1,061
Percent Change (as a percent)	2.40%		(14.50%)
MEDICAL DEVICES | Orthopaedics | HIPS | U.S.
Sales by segment of business
Sales to customers	$ 221	204	$ 564	633
Percent Change (as a percent)	8.70%		(10.90%)
MEDICAL DEVICES | Orthopaedics | HIPS | International
Sales by segment of business
Sales to customers	$ 124	133	$ 344	428
Percent Change (as a percent)	(7.20%)		(19.80%)
MEDICAL DEVICES | Orthopaedics | KNEES
Sales by segment of business
Sales to customers	$ 308	344	$ 825	1,085
Percent Change (as a percent)	(10.90%)		(24.00%)
MEDICAL DEVICES | Orthopaedics | KNEES | U.S.
Sales by segment of business
Sales to customers	$ 205	209	$ 527	650
Percent Change (as a percent)	(1.90%)		(19.00%)
MEDICAL DEVICES | Orthopaedics | KNEES | International
Sales by segment of business
Sales to customers	$ 102	136	$ 298	435
Percent Change (as a percent)	(24.80%)		(31.50%)
MEDICAL DEVICES | Orthopaedics | TRAUMA
Sales by segment of business
Sales to customers	$ 685	677	$ 1,892	2,034
Percent Change (as a percent)	1.30%		(7.00%)
MEDICAL DEVICES | Orthopaedics | TRAUMA | U.S.
Sales by segment of business
Sales to customers	$ 433	415	$ 1,194	1,239
Percent Change (as a percent)	4.20%		(3.60%)
MEDICAL DEVICES | Orthopaedics | TRAUMA | International
Sales by segment of business
Sales to customers	$ 253	262	$ 698	795
Percent Change (as a percent)	(3.40%)		(12.20%)
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER
Sales by segment of business
Sales to customers	$ 745	778	$ 1,947	2,384
Percent Change (as a percent)	(4.30%)		(18.30%)
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER | U.S.
Sales by segment of business
Sales to customers	$ 449	472	$ 1,142	1,427
Percent Change (as a percent)	(4.90%)		(20.00%)
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER | International
Sales by segment of business
Sales to customers	$ 295	306	$ 805	957
Percent Change (as a percent)	(3.40%)		(15.80%)
MEDICAL DEVICES | Surgery
Sales by segment of business
Sales to customers	$ 2,152	2,311	$ 5,803	7,059
Percent Change (as a percent)	(6.90%)		(17.80%)
MEDICAL DEVICES | Surgery | U.S.
Sales by segment of business
Sales to customers	$ 913	940	$ 2,247	2,867
Percent Change (as a percent)	(3.00%)		(21.70%)
MEDICAL DEVICES | Surgery | International
Sales by segment of business
Sales to customers	$ 1,239	1,371	$ 3,556	4,192
Percent Change (as a percent)	(9.60%)		(15.20%)
MEDICAL DEVICES | Surgery | ADVANCED
Sales by segment of business
Sales to customers	$ 1,000	1,010	$ 2,723	3,019
Percent Change (as a percent)	(1.10%)		(9.80%)
MEDICAL DEVICES | Surgery | ADVANCED | U.S.
Sales by segment of business
Sales to customers	$ 421	409	$ 1,079	1,209
Percent Change (as a percent)	3.00%		(10.70%)
MEDICAL DEVICES | Surgery | ADVANCED | International
Sales by segment of business
Sales to customers	$ 579	602	$ 1,644	1,811
Percent Change (as a percent)	(3.90%)		(9.20%)
MEDICAL DEVICES | Surgery | GENERAL
Sales by segment of business
Sales to customers	$ 1,152	1,301	$ 3,080	4,040
Percent Change (as a percent)	(11.40%)		(23.80%)
MEDICAL DEVICES | Surgery | GENERAL | U.S.
Sales by segment of business
Sales to customers	$ 492	531	$ 1,168	1,658
Percent Change (as a percent)	(7.60%)		(29.60%)
MEDICAL DEVICES | Surgery | GENERAL | International
Sales by segment of business
Sales to customers	$ 660	769	$ 1,912	2,381
Percent Change (as a percent)	(14.10%)		(19.70%)
MEDICAL DEVICES | Vision
Sales by segment of business
Sales to customers	$ 1,081	1,193	$ 2,843	3,483
Percent Change (as a percent)	(9.40%)		(18.40%)
MEDICAL DEVICES | Vision | U.S.
Sales by segment of business
Sales to customers	$ 473	459	$ 1,160	1,366
Percent Change (as a percent)	3.10%		(15.10%)
MEDICAL DEVICES | Vision | International
Sales by segment of business
Sales to customers	$ 608	734	$ 1,683	2,117
Percent Change (as a percent)	(17.20%)		(20.50%)
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER
Sales by segment of business
Sales to customers	$ 830	893	$ 2,198	2,559
Percent Change (as a percent)	(7.10%)		(14.10%)
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | U.S.
Sales by segment of business
Sales to customers	$ 375	339	$ 924	993
Percent Change (as a percent)	10.90%		(6.90%)
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | International
Sales by segment of business
Sales to customers	$ 455	555	$ 1,274	1,566
Percent Change (as a percent)	(18.10%)		(18.70%)
MEDICAL DEVICES | Vision | SURGICAL
Sales by segment of business
Sales to customers	$ 251	299	$ 645	923
Percent Change (as a percent)	(16.30%)		(30.20%)
MEDICAL DEVICES | Vision | SURGICAL | U.S.
Sales by segment of business
Sales to customers	$ 98	120	$ 236	373
Percent Change (as a percent)	(18.90%)		(36.80%)
MEDICAL DEVICES | Vision | SURGICAL | International
Sales by segment of business
Sales to customers	$ 153	$ 180	$ 409	$ 551
Percent Change (as a percent)	(14.60%)		(25.70%)